Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03115411 · ClinicalTrials.gov registry record · NA
Prospective Evaluation of Winged Biliary Stent Patency in Patients With Benign Biliary Obstruction
A NA study of Biliary Stricture, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT03115411: Completed NA study of Biliary Stricture, sponsored by Stanford University.
NCT03115411 is a NA study of Biliary Stricture that has completed, run by Stanford University. The registered enrollment target is 23 participants, below the 262-participant average among 3 other Biliary Stricture trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03115411, a NA study of Biliary Stricture, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluation of ERCP with placement of a winged plastic biliary stent without a lumen for management of benign biliary strictures.
Primary Outcome
Evaluation of laboratory studies and clinical status to assess for stent patency/evidence of biliary obstruction
Conditions Studied
Interventions
- DEVICE Winged biliary stent (ViaDuct™)
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2011-09-06 |
| Est. Completion | 2018-04-10 |
| Phase | NA |
What the finished NCT03115411 record still lists
NCT03115411 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 262-participant average among 3 other Biliary Stricture trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Biliary Stricture appearing as the primary indexed condition, and to 1 intervention - of which Winged biliary stent (ViaDuct™) is the first listed.
NCT03115411 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03115411 about?
NCT03115411 is a clinical study titled "Prospective Evaluation of Winged Biliary Stent Patency in Patients With Benign Biliary Obstruction". Evaluation of ERCP with placement of a winged plastic biliary stent without a lumen for management of benign biliary strictures.
What is the current status of trial NCT03115411?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2011-09-06. Estimated completion is 2018-04-10.
What conditions does trial NCT03115411 study?
This clinical trial studies the following conditions: Biliary Stricture.
What interventions are being tested in trial NCT03115411?
The interventions under investigation include: Winged biliary stent (ViaDuct™) (DEVICE).
Who is sponsoring clinical trial NCT03115411?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03115411 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Biliary Stricture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI